ESC 365 - Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events

ESC Premium Access

Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events

Session: Poster Session 3 - Diabetes, adiposity and metabolic syndrome

Topic: Pharmacotherapy

Speaker: Doctor M. Husain (Toronto, CA)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Mansoor Husain

University of Toronto, Toronto (Canada)

7 presentations

2 followers

8 more presentations in this session

Vascular endothelial growth factor-C and mortality in patients with diabetes and suspected coronary artery disease: from the ANOX study

Speaker: Doctor T. Unoki (Kumamoto, JP)

Cardiovascular outcomes associated with SGLT2 vs DPP4 inhibitors in type 2 diabetic patients with and without established cardiovascular diseases: a propensity score-matched study

Speaker: Professor B. Yan (Hong Kong, CN)

The combined treatment with glucagon like peptide-1 analogues and sodium-glucose co-transporter 2 causes a greater improvement of arterial stiffness than each treatment alone in type 2 diabetes .

Speaker: Doctor I. Ikonomidis (Athens, GR)

Cardiovascular risk according to add-on therapy in patients with type 2 diabetes

Speaker: Mr D. Aagaard (Copenhagen, DK)

Lentiviral transfer of interleukin 4 gene to 3T3-L1 adipocytes prevents development of lipid-induced insulin resistance

Speaker: Ms S. Michurina (Moscow, RU)

Access the full session

Poster Session 3 - Diabetes, adiposity and metabolic syndrome

Speakers: Doctor M. Husain, Doctor T. Unoki, Professor B. Yan, Doctor I. Ikonomidis, Mr D. Aagaard...

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by